Literature DB >> 23704188

Genome Sequence of Pseudomonas aeruginosa PA45, a Highly Virulent Strain Isolated from a Patient with Bloodstream Infection.

Nicola Segata1, Annalisa Ballarini, Olivier Jousson.   

Abstract

Pseudomonas aeruginosa is a ubiquitous opportunistic pathogen causing a broad range of infections in humans. We provide the draft genome sequence of the recently identified and highly virulent P. aeruginosa PA45 strain. Its 6.6-Mb genome contains 6,822 genes, including an unparalleled number of virulence genes, which might explain its aggressive phenotype.

Entities:  

Year:  2013        PMID: 23704188      PMCID: PMC3662828          DOI: 10.1128/genomeA.00289-13

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Pseudomonas aeruginosa is a ubiquitous environmental bacterium and an opportunistic pathogen causing acute and chronic infections in the urinary tract, blood, skin, and lungs of immunocompromised patients. P. aeruginosa strains and virulent variants causing severe human chronic infections, e.g., to the lungs of cystic fibrosis patients, have been extensively studied, while strains causing acute human infections need further investigation, primarily to define their pathogenic potential. In a previous study (1), we characterized the virulence phenotype of a collection of clinical P. aeruginosa strains that cause acute infections and identified the highly aggressive PA45 strain, a clinical isolate that caused a severe acute bloodstream infection in a hospitalized oncology patient who was undergoing chemotherapy treatment. Here, we report the draft genome sequence of the P. aeruginosa PA45 strain, thus providing new information about the genomic determinants underlying its highly aggressive phenotype. The P. aeruginosa PA45 genome was sequenced using the 454 GS-FLX (Roche) platform, generating 854,562 raw reads, for a total of 332,906,173 bp with 50× average coverage (398 average read length). Using the Newbler 2.8 assembler, reads were assembled into 124 contigs with an N50 size of 220,690. Open reading frames, rRNAs, and tRNAs were identified and annotated using the pipeline provided by the Integrated Microbial Genomes-Expert Review (2). The genome is 6,615,955 bp long, exceeding the size of 9 of the 12 P. aeruginosa genomes available in the IMG database (3) (average 6,474,902 bp; standard deviation [SD], 226,090). The average G+C content is 66.3%, and 6,822 genes, including 3 rRNA and 58 tRNA genes, were identified. The annotation procedure successfully profiled 82.1% of genes with a specific function, 78.9% with a COG assignment, 48.77% with a KEGG orthology family, and 84.3% with Pfam domains. Of the 3,832 core genes shared by all 12 P. aeruginosa sequenced strains (4), 3,822 (99.7%) genes are found also in PA45, confirming the completeness of the core genome assembly and the presence of all functional modules characterizing this species. Compared to the accessory genome, which is unique to each of the already-sequenced strains, PA45 was found to be closely related to P. aeruginosa C3719 (GenBank accession no. NZ_AAKV00000000), carrying 74.4% of its unique genes (e-value, <1e – 20; length, >200 bp), whereas P. aeruginosa NCGM2.S1 (GenBank accession no. AP012280) and P. aeruginosa 39016 (GenBank accession no. AEEX00000000) had the smallest number of overlapping strain-specific genes (20.8% and 23.0%, respectively). Compared to the other 12 P. aeruginosa strains, PA45 comprises the highest number of virulence genes (829) in its genome, according to the BLASTx translated search we performed against the Virulence Factor database (DB) (5). Focusing on the pathogenicity islands PAPI-1 and PAPI-2 carried by the highly virulent PA14 strain (GenBank accession no. NC_008463), 82 out of 113 PAPI-1 genes and 16 out of 19 PAPI-2 genes were found in PA45 (e-value, <1e − 20). The unprecedented high abundance of virulence gene homologues carried by the PA45 strain correlates well with its highly aggressive phenotype.

Nucleotide sequence accession numbers.

This Whole-Genome Shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. APMD00000000. The version described in this paper is the first version, accession no. APMD01000000.
  5 in total

1.  IMG ER: a system for microbial genome annotation expert review and curation.

Authors:  Victor M Markowitz; Konstantinos Mavromatis; Natalia N Ivanova; I-Min A Chen; Ken Chu; Nikos C Kyrpides
Journal:  Bioinformatics       Date:  2009-06-27       Impact factor: 6.937

2.  Clinical populations of Pseudomonas aeruginosa isolated from acute infections show a wide virulence range partially correlated with population structure and virulence gene expression.

Authors:  Hussnain A Janjua; Nicola Segata; Paola Bernabò; Sabrina Tamburini; Albert Ellen; Olivier Jousson
Journal:  Microbiology       Date:  2012-05-03       Impact factor: 2.777

3.  IMG: the Integrated Microbial Genomes database and comparative analysis system.

Authors:  Victor M Markowitz; I-Min A Chen; Krishna Palaniappan; Ken Chu; Ernest Szeto; Yuri Grechkin; Anna Ratner; Biju Jacob; Jinghua Huang; Peter Williams; Marcel Huntemann; Iain Anderson; Konstantinos Mavromatis; Natalia N Ivanova; Nikos C Kyrpides
Journal:  Nucleic Acids Res       Date:  2012-01       Impact factor: 16.971

4.  Toward an efficient method of identifying core genes for evolutionary and functional microbial phylogenies.

Authors:  Nicola Segata; Curtis Huttenhower
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

5.  VFDB 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors.

Authors:  Lihong Chen; Zhaohui Xiong; Lilian Sun; Jian Yang; Qi Jin
Journal:  Nucleic Acids Res       Date:  2011-11-08       Impact factor: 16.971

  5 in total
  1 in total

1.  Decoding Genetic Features and Antimicrobial Susceptibility of Pseudomonas aeruginosa Strains Isolated from Bloodstream Infections.

Authors:  Tomasz Bogiel; Dagmara Depka; Mateusz Rzepka; Agnieszka Mikucka
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.